All insights
Canada / Health CanadaKnowledge baseAs of: 2026-05-29

MDL vs MDEL in Canada: what founders should sort out before a consultant call

If your team keeps asking whether a Canada launch needs a Medical Device Licence (MDL), a Medical Device Establishment Licence (MDEL), or both, the first useful move is not guessing. Sort the question into two buckets: device class and company activity. Health Canada's public guidance treats them differently, and that distinction is what makes the consultant conversation shorter and more valuable. This is a source-backed evidence organizer for the consultant handoff, not a licensing determination.

Role

Founder, operator, or first regulatory hire planning Canada launch activities

Scenario

The company is budgeting a Canada launch and internal stakeholders are mixing up product licensing with establishment licensing.

Concrete problem

The team does not know whether the next decision depends on device class, importer or distributor activity, annual review duties, or public licence checks.

Short answer

Use MDL questions when the team is trying to understand a Class II, III, or IV device's product licence status, public active-licence record, and product-level submission package. Use MDEL questions when the team is trying to understand whether its planned Canadian activities, such as importing, distributing, renting, or certain Class I manufacturing, trigger establishment-licensing duties, annual review, and fee-handling. A founder-friendly handoff pack should bring both buckets to the consultant, clearly separated.

Pre-production brief

Role
Founder, operator, or first regulatory hire planning Canada launch activities
Scenario
The company is budgeting a Canada launch and internal stakeholders are mixing up product licensing with establishment licensing.
Concrete problem
The team does not know whether the next decision depends on device class, importer or distributor activity, annual review duties, or public licence checks.
Available inputs
Product description, known device class assumptions, proposed importer or distributor model, target customer path, and any existing public licence screenshots or consultant notes.
Useful output
A plain-language comparison table, a question list for the consultant call, and a source ledger tied to current Health Canada guidance.
TrueMedDevice role
Translate official public guidance into a reusable comparison pack without making the licensing determination.

MDL versus MDEL: what to separate before the call

Question areaMDL bucketMDEL bucket
What it is aboutProduct licensing for Class II, III, and IV devices.Establishment licensing tied to activities such as importing or distributing.
Primary trigger to investigateThe device class and product-level licence status.What the company does in Canada: import, distribute, or certain Class I manufacturing activities.
Public list to checkMedical Devices Active Licence Listing (MDALL).List of active MDEL holders and GUI-0016 activity examples.
Recurring calendar itemClass II, III, and IV right-to-sell and licence-maintenance planning may matter.Annual licence review before April 1 each year.
Question for the consultantWhat class and product-licence pathway should be reviewed?Do our planned activities and exemptions mean we need an establishment licence?

This table is a preparation aid, not a licensing decision. The point is to stop a consultant meeting from starting with category confusion.

Workflow: how to turn the confusion into a useful handoff

  1. 1. Write the product statement in plain language. Avoid starting with a guessed licence label. Start with what the device is, who uses it, and what activity the company plans to perform in Canada.
  2. 2. Split the notes into product versus company activity. Product questions feed the MDL side. Importing, distributing, renting, donating, and Class I manufacturing questions feed the MDEL side.
  3. 3. Check the public MDL side. Search the Medical Devices Active Licence Listing for similar licensed devices and capture screenshots or links as class clues, not final answers.
  4. 4. Check the public MDEL side. Use GUI-0016 to map your planned Canadian activity against Health Canada's examples and note where an exemption question still exists.
  5. 5. Add the recurring operational items. For MDEL questions, note annual licence review timing and fee handling. For MDL-side product planning, keep right-to-sell or other product-maintenance questions separate from the establishment licence topic.
  6. 6. Hand the consultant a question list, not a pile of tabs. A short list of open licensing questions beats sending fifteen browser tabs with no structure.

Workload and cost framing

The cost problem here is usually not just the licence fee. It is consultant time spent untangling avoidable confusion between product licensing and establishment licensing.

Health Canada's current fee table lists the Medical Device Establishment Licence fee at C$5,519 as of April 1, 2026. The fee guidance also says new MDEL applications, reinstatements, and annual licence review applications use the same flat-fee structure. If your team is budgeting Canada launch work, those operational questions should be in the handoff pack before the call starts.

Source ledger

  • Health Canada issues two licence types for medical devices in Canada: MDL and MDEL.
    Official source
  • MDLs are issued for Class II, III, and IV devices, while MDELs are issued to companies that import Class I to IV, distribute Class I to IV, or manufacture Class I devices.
    Official source
  • Class I devices do not require an MDL, but importers, distributors, and some manufacturers still need to examine MDEL requirements and exemptions.
    Official source
  • GUI-0016 says it covers who requires an MDEL and that active MDEL holders must submit an annual licence review before April 1 each year.
    Official source
  • GUI-0016 includes activity-based examples showing when importing, distributing, renting, donating, or Class I manufacturing can require an MDEL or qualify for an exemption.
    Official source
  • Health Canada says all active MDEL holders must submit an annual licence review application before April 1, even when there are no changes, and must pay the fee upon invoicing.
    Official source
  • The MDEL fee guidance says new applications, reinstatements, and annual licence review applications use the same flat-fee structure for the fiscal year.
    Official source
  • Health Canada's fee table lists the Medical Device Establishment Licence fee as C$5,519 as of April 1, 2026.
    Official source
  • The Medical Devices Active Licence Listing is the public source used to verify active MDLs for licensed devices in Canada.
    Official source

FAQ

Does Class I always mean MDEL and never MDL?

Class I devices do not require an MDL, but whether an MDEL is required depends on the activity and whether an exemption applies. Health Canada lists common activity-based examples in GUI-0016, and qualified reviewers still need to confirm how your planned sales model fits those rules.

If we already found similar devices in MDALL, does that mean we only need an MDL?

No. MDALL can show that similar Class II, III, or IV devices hold active medical device licences, but company activities such as importing or distributing may still raise separate establishment-licensing questions. The public listing helps the handoff; it does not decide your obligations.

What is the recurring operational task people forget about MDELs?

Health Canada's GUI-0016 says active MDEL holders must submit an annual licence review before April 1 each year. Teams often budget for the initial application but forget the yearly review cycle and fee handling.

Does TrueMedDevice decide whether we need an MDL, an MDEL, or both?

No. TrueMedDevice does not determine class, MDL need, MDEL need, pathway, exemption status, compliance status, safety, effectiveness, or legal obligations. We organize official-source evidence so qualified RA/QA professionals or consultants can review and decide.

Boundary statement

This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. We prepare a source-backed Health Canada / MDALL / public-source evidence pack so qualified RA/QA professionals or regulatory consultants can review and decide.